MedPlus Health Services Ltd.

As of June 30, 2026, MedPlus Health Services Ltd. carries a market capitalization of 97.35B, placing it among publicly traded companies globally. Its enterprise value stands at 97.35B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

MedPlus Health Services Ltd.'s next confirmed earnings release is scheduled for October 27, 2026.

As of June 30, 2026, MedPlus Health Services Ltd. has 120.08M shares outstanding.

As of June 30, 2026, MedPlus Health Services Ltd. trades at a trailing price-to-earnings ratio of 49.29.

As of June 30, 2026, MedPlus Health Services Ltd. trades at an EV/EBITDA multiple of 16.45 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 1.37 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 32.50 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. These enterprise value multiples are built on an enterprise value of 97.35B versus a market cap of 97.35B, with the gap driven by net debt and cash on the balance sheet.

These figures are as of June 30, 2026.

These figures cover the twelve months ended June 30, 2026. The company generates approximately 2.69M in revenue per employee across its workforce of 26,346.50, a quick read on workforce productivity versus industry peers.

Over the twelve months ended June 30, 2026, MedPlus Health Services Ltd. recorded 510.01M in income tax expense. That works out to an effective tax rate of 20.54, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 2.48B, leaving 1.97B in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 22, 2026, MedPlus Health Services Ltd.'s stock has declined approximately 21.93% over the past 52 weeks. The 50-day moving average sits at 653.56, while the 200-day moving average is 788.88.

Over the twelve months ended June 30, 2026, MedPlus Health Services Ltd. generated 70.93B in revenue and converted that into 1.97B in net income, yielding earnings per share of 16.42. EBITDA reached 5.92B, while operating income came in at 3.00B.

Over the twelve months ended June 30, 2026, MedPlus Health Services Ltd. posted a gross margin of 25.79, reflecting its pricing power and cost economics. The operating margin of 4.22 and net profit margin of 2.78 provide insight into operational efficiency.